Time-limited acalabrutinib plus venetoclax improves outcomes vs chemoimmunotherapy, offering the first FDA-approved all-oral fixed-duration CLL option, explains Adam Kittai, MD. The study compared ...
Erratum: BO-112 Plus Pembrolizumab for Patients With Anti–PD-1–Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203 The article by Sharman et al entitled “Phase III Trial of ...
A seven-year-old girl is battling acute myeloid leukemia for the second time at Boston Children's Hospital. She is scheduled to undergo a stem cell transplant in May, which will require chemotherapy ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Rewiring your brain requires understanding two layers of cognition: the thought itself and ...
Project Shirley: Fear of recurrence and risk communication in Australian HR+ HER2– early breast cancer patients. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
"No one actually feels the pain of their heart breaking into a million pieces until you lose a child," Marie Fellows tells PEOPLE about her daughter's death Leukaemia UK A mother has opened up about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results